Case Report
HIV-Associated Vacuolar Myelopathy and HIV-Associated Neurocognitive Disorder as an Initial Presentation in HIV Infection
| | Laboratory tests | Results | Reference range |
| | Hemoglobin | 8.4 gm/dl | 12–15.5 g/dL | | WBC | 4 K/µl | 4–10 K/µl | | Neutrophil | 82% | 40–70% | | Lymphocyte | 12% | 20–45% | | Platelet count | 150 K/µl | 150–350 K/µl | | PBF | Normocytic normochromic anemia | | | ESR | 35 mm in 1st hour | 0–38 | | Creatinine | 0.8 mg/dl | 0.7–1.5 mg/dl | | S. electrolyte | Na: 136 mmol/L | Na: 135–145 mmol/L | | K: 3.5 mmol/L | K: 3.5–5 mmol/L | | Cl: 97 mmol/L | Cl: 95–105 mmol/L | | CO2: 26 mmol/L | CO2: 22–30 mmol/L | | S. bilirubin | 0.29 mg/dl | 0.2–1.2 mg/dl | | S. TSH | 2.3 mIU/L | 0.5–5.0 mIU/L | | ALT | 131 U/L | Up to 40 | | Prothrombin time | 13 sec | | | ANA | 13.29 AU/mL | 0–40 AU/mL | | CPK | 22 U/L | 30–135 | | VDRL | Nonreactive | | | TPHA | Negative | | | Toxoplasma antibodies | Negative | | | HBsAg | Negative | | | Anti HCV | Negative | | | Vitamin B12 | 669 pg/ml | 239–931 pg/ml | | HIV Ag/Ab combo assay | Positive | | | CD4 count | 54/µL | 424–1509 µL |
|
|
PBF, peripheral blood film; ALT, alanine transaminase; ANA, antinuclear antibodies; CPK, creatine phosphokinase; VDRL, venereal disease research laboratory test; TPHA, Treponema pallidum hemagglutination assay.
|
